维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Knight ZA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Isoformselective phosphoinositide 3-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia:a novel therapeutic approach显示文摘	Niedermeier M Hennessy BT Knight ZA	2009	Blood2009，113，22：	1
2	Discovery of drug-resistant and drug-sensitizing mutations in the oncogenic PI3K isoform p110 alpha 显示文摘	Zunder ER Knight ZA Houseman BT	2008	Cancer Cell2008，14，2：	1
3	PhosphospeciGc proteolysis for mapping sites of protein phosphorylation显示文摘	Knight ZA Schilling B Row RH	2003	Nat Biotechnol2003，21，9：	1
4	A pharmacological map of the PI3K family defines a role for pll0 alpha in insulin signaling显示文摘	Knight ZA Gonzalez B Feldrnan ME	2006	Ce112006，125，4：	1
5	A critical rolefor mTORCl in erythropoiesis and anemia 显示文摘	KNIGHT ZA SCHMIDT SF BIRSOY K	2014	Elife2014，，01：	1
6	Chemically targeting the PI3K family显示文摘	Knight ZA Shokat KM	2007	Biochem Soc Trans2007，35，2：	1
7	Phosphospecific proteolysis for mapping sites of protein phosphorylation显示文摘	Knight ZA Schilling B Row RH	2003	Nat Biotechnol2003，21，：	1
8	Targeting the cancer ki- nnme through polypharmacology显示文摘	KNIGHT ZA LIN H SHOKAT KM	2010	Nat Rev Cancer2010，10，2：	1
9	Phosphospecific proteolysis for mapping sites of protein phosphorylation显示文摘	Schilling B Row RH	2003	Nat Biotechnol2003，21，9：	1
10	Phosphospecitlc proteolysis for mapping sites of protein phosphorylation显示文摘	Knight ZA Schilling B Row RH	2003	Nat Biotechnol2003，21，9：	1
11	A doal PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma 显示文摘	Fan QW Knight ZA Goldenberg DD	2006	Cancer Cell2006，9，5：	1
12	A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma显示文摘	Fan QW Knight ZA Goldenberg DD	2006	Cancer Cell2006，9，5：	1
13	Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia:a novel therapeutic approach显示文摘	Niedermeier M Hennessy BT Knight ZA	2009	Blood2009，113，：	1
14	A dual PI3 kinase/ mTOR inhibitor reveals emergent efficacy in glioma 显示文摘	Fan QW Knight ZA Goldenberg DD	2006	Cancer Cell2006，9，5：	1
15	Isoform - selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell - mediated drug resistance in chronic lymphocytic, leukemia: a novel therapeutic approach 显示文摘	Niedermeier M Hennessy BT Knight ZA	2009	Blood2009，113，22：	1
16	A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma显示文摘	Fan QW Knight ZA Goldenberg DD		0，，05：	1
17	EGFR signals to mTOR through PKC and independently of Akt in glioma显示文摘	Fan QW Cheng C Knight ZA	2009	Sci Signal2009，55，1：	1
18	Targeting the cancer kinome through polypharmacology 显示文摘	Knight ZA Lin H Shokat KM	2010	Nat Rev Cancer2010，10，2：	1
19	Isoform-specific phoaphoinositide 3-kinase inhibitors from an arylmorpholine scaffold显示文摘	Knight ZA Chiang GG Alaimo PJ	2004	Bioorg Med Chem2004，12，17：	1
20	A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling 显示文摘	Knight ZA Gonzalez B Feldman ME	2006	Ce112006，125，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示